International Health Economics & Pharmacoeconomics (M.Sc.)
Wiesbaden, Germany
DURATION
4 Semesters
LANGUAGES
English
PACE
Full time
APPLICATION DEADLINE
Request application deadline
EARLIEST START DATE
Request earliest startdate
TUITION FEES
Request tuition fees
STUDY FORMAT
On-Campus
Introduction
Worldwide popular with specialists in the pharmaceutical and healthcare industry and ideally suited for scientists with the desire for professional reorientation:
The International Health Economics & Pharmacoeconomics (M.Sc.) Master’s program in Wiesbaden qualifies you for higher positions in research and education, as well as in the public and the private sector. More than three quarters of your fellow students will come from abroad and this very much leaves its mark on our course. Here, you will develop a set of skills that will equip you for the global challenges expected to face a graduate of health economics. Alongside internationality and interdisciplinarity, this Master’s program includes a large practical component. You will spend six months working at a company as part of your internship.
The study program is known and loved by specialists in the pharmaceutical and healthcare sector around the world and is ideal for natural scientists looking for a change of career. Become an expert in licensing processes and pricing. Gain the necessary qualifications for more senior roles at public authorities, institutes, or companies in the industry. At around 75%, the proportion of international students is a defining characteristic of the study program. You will not only acquire the skills to meet the international requirements for qualified health economists, but also familiarize yourself with healthcare systems from many cultural areas and benefit from an intensive exchange of ideas with your fellow students.
In addition to internationality and interdisciplinarity, the Master’s program is characterized by its high level of practical content: As part of your internship, you will spend six months on in-company placements. Around 80% of students also complete their Master’s thesis there and many are then taken on as salaried employees.
Admissions
Scholarships and Funding
Several scholarship options are available. Please check the university website for more information.
Curriculum
With us, you will learn to understand and analyze industry processes from an economic perspective. We will teach you methods such as statistics and cost-benefit analysis. As a graduate, you will be aware of how healthcare systems are established and funded, what political and regulatory factors play a role in the licensing of new drugs and medical devices, and how pricing structures work.
The Master’s program runs for two years with an internship in the third semester. Program content at a glance:
- Economics and Pharmacoeconomics
- Research and Statistical Skills
- Global Health Product Development and Regulations
- Economic Evaluation and Modeling Techniques
- Ethical Resource Allocation
- Healthcare Systems and Health Policy
- Strategic Management, Market Strategies, and Market Access
- International HTA Processes, Pricing, and Reimbursement
Program Outcome
ECTS credits : 120
Program Tuition Fee
Career Opportunities
With expertise in pharmacoeconomics and health economics, as well as methodological and strategic capabilities and an excellent knowledge of English, you will lay the foundations for your career in an international environment. Potential future positions include:
- Health economics specialist: Prepare cost-benefit analyzes, develop studies and develop health policy concepts.
- International Market Access Manager: Develop market access strategies for different countries and act at the interface between global and local market access.
- Pricing Manager: Set the prices for drugs and medical products taking into account the respective country specifications, observe the competition and keep an eye on regional market conditions.
- Regulatory Affairs Expert: Be responsible for all regulatory issues related to market access.
- Payer Relations Manager: Present the added value of the product and defend it against health insurers and other responsible persons in the health system.